Navigation Links
Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
Date:8/18/2010

NEW YORK, Aug. 18 /PRNewswire-FirstCall/ -- Regenicin, Inc. (OTC Bulletin Board: WDSTD), a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").  Lonza Walkersville is a subsidiary of Lonza Group Ltd. (SIX: LONN), one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries and the largest cell therapy manufacturer in the world.

The Lonza Agreement provides Regenicin with the worldwide marketing rights to a proprietary tissue-engineered skin substitute technology intended to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures.  Regenicin's management team intends to use its expertise, with the assistance of Lonza Walkersville, to further enhance its capabilities and seek approval by the U.S. Food and Drug Administration for commercial sale. Regenicin plans to seek marketing approval for this revolutionary product throughout the world under the brand name PermaDerm™.  

Pursuant to the Lonza Agreement, Lonza will retain exclusive manufacturing rights for PermaDerm™ products.  Additionally, a license to the patent rights and related key intellectual property comprising the technology, developed at the University of California, University of Colorado, the University of Cincinnati and Shriners Hospitals for Children, may be acquired by Regenicin if FDA approval is obtained.

Regenicin secured the initial financing through a combination of convertible loans and a private placement of its common stock with several major institutions and accredited investors. NewOak Capital, Inc. and Smith Point, Ltd. acted as co-p
'/>"/>

SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
2. Resverlogix Completes Dosing for ASSERT Trial
3. Xybion Completes Acquisition of Stelex and Vital-Path, Leaders in Business Process Software and Consulting Services for Regulated Industries, from GE Healthcare
4. Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study
5. Hendrick Construction Completes Oak Ridge National Laboratory Expansion
6. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
7. Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
8. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
9. EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
10. APT Pharmaceuticals Completes Enrollment in Phase III for Inhaled Cyclosporine
11. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Follow us on LinkedIn ... the world over, due to its use of ... marketplace is expected to come from increasing adoption ... Several sub-Saharan countries in the African continent, which ... genetically engineered crop production strategies. Rising focus on ...
(Date:9/23/2014)... Sept. 23, 2014 News Facts ... India devoted to genome-based research for human health ... is taking a bite out of oral cancer with ... in India with the help of ... DataDirect Networks (DDN). , To fuel its cutting-edge cancer ...
(Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart ... in the recent ‘Hype Cycle for Life Sciences 2014 ... details key insights pertaining to the benefits in the ... Michael Shanler and Stephen Davies, “The use of these ... with scientific stakeholders, and support collaboration and innovation strategies ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the ... expanding a Central Texas footprint that includes Round Rock, ... office for the region’s most established practice will provide ... Austin, Buda, Kyle and San Marcos communities. , ... directly to individuals and couples living in and around ...
Breaking Biology Technology:Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3
... MMPSense(TM) 750 FAST is Presented at AACR 100th Annual ... leader in fluorescence in vivo imaging from ... new FAST ("Fluorescent Activatible Sensor Technology") imaging ... and drug response in vivo . Newly ...
... (Nasdaq: MYL ) today announced that Matrix ... a 71.2% controlling interest, has been selected by the ... the primary supplier of five antiretroviral (ARV) drugs used ... selected as the primary supplier of seven ARVs used ...
... for the Company Building on Milestones with Recent ... DXL625 monoclonal antibodies appear to ... to attach and deplete NHL in late stage ... Biotechnology Inc. (Toronto Stock Exchange: IXS.V, http://www.ixsbio.com ...
Cached Biology Technology:VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo 2VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo 3VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo 4Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments 2Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments 3AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 2AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 3
(Date:9/22/2014)... the country selected by the National Institutes of ... a $2 million grant designed to expose ... graduate trainees to career opportunities that go beyond ... , The award funds development of the Rutgers ... It includes courses, seminars, shadowing, mentoring and networking ...
(Date:9/22/2014)... manufacturing (AM), or 3D printing, has rapidly advanced ... components strong enough for structural applications. However, developing ... well as quality standards to test the manufactured ... Engineers at the University of Pittsburgh,s Swanson School ... and simulation (M&S) technology and new qualification standards ...
(Date:9/22/2014)... you,re overweight, you may be at greater risk ... disease and cancer, according to a new study ... psychological stress can trigger biological responses similar to ... While normal inflammation is an important part of ... to chronic and life-threatening diseases. , In ...
Breaking Biology News(10 mins):Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3Pitt engineers receive grants to enhance additive manufacturing 2Pitt engineers receive grants to enhance additive manufacturing 3Obesity and stress pack a double hit for health 2
... An Australian bird has been found to produce smaller, ... of other helper birds that provide child-care assistance. ... and breed more often than females without helpers. ... today made the front cover of Science. In ...
... mice, carbon dioxide often means danger - too many ... hungry predator exhaling nearby. Mice have a way of ... shows that a special set of olfactory neurons is ... predicted increases in atmospheric carbon dioxide may affect animal ...
... Berkeley -- Delaying having kids to help raise the ... you want to reproduce, but many African starlings have ... of their savanna habitats, according to a new study ... It appears in the Aug. 21 issue of the ...
Cached Biology News:Mother's little helpers 2Mice use specialized neurons to detect carbon dioxide in the air 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 3Savanna habitat drives birds, and perhaps others, to cooperative breeding 4
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Mouse anti-JNK (PT183/185) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: